您的位置: 首页 > 农业专利 > 详情页

substituted 2,3-hydroimidazo [1,2-c] quinazoline salts
专利权人:
BAYER INTELLECTUAL PROPERTY GMBH
发明人:
HANS-CHRISTIAN MILITZER,HARTWIG MÜLLER,JAN GEORG PETERS
申请号:
BR112013025549
公开号:
BR112013025549A2
申请日:
2012.03.29
申请国别(地区):
BR
年份:
2016
代理人:
摘要:
patent summary: "substituted 2,3-hydroimidazo [1,2-c] quinazoline salts". The present invention relates to: the dihydrochloride salt of formula 2-amino-n- [7-methoxy-8- (3-morpholin-4-ylpropoxy) -2,3-dihydroimidazo [1,2- c] quinazolin-5-yl] pyrimidin-5-carboxamide (ii): (ii), or a tautomer, solvate or hydrate thereof; - the methods of preparing said dihydrochloride salt; - said dihydrochloride salt for the treatment and / or prophylaxis of a disease; the use of said dihydrochloride salt for the preparation of a medicament for the treatment and / or prophylaxis of a disease, in particular of a hyperproliferative disorder and / or angiogenesis, more particularly for the treatment or prophylaxis of a cancer, particularly cancer of lung, in particular non-small cell lung carcinoma, colorectal cancer, melanoma, pancreatic cancer, hepatocyte carcinoma, pancreatic cancer, hepatocyte carcinoma or breast cancer; a pharmaceutical composition comprising said dihydrochloride salt; and - a pharmaceutical combination comprising said dihydrochloride salt in combination with one or more other pharmaceutical agents.resumo patente de invenção: "sais de 2,3-hidroimidazo[1,2-c]quinazolina substituídos". a presente invenção refere-se: - ao sal de dicloridrato de fórmula 2-amino-n-[7-metóxi-8-(3-morfolin-4-ilpropóxi)-2,3-di-hidroimidazo-[1,2-c]quinazolin-5-il]pirimidina-5-carboxamida (ii): (ii), ou um tautômero, solvato ou hidrato do mesmo ; - aos métodos de preparar referido sal de dicloridrato; - ao referido sal de dicloridrato para o tratamento e/ou profilaxia de uma doença; - ao uso de referido sal de dicloridrato para a preparação de um medicamento para o tratamento e/ou profilaxia de uma doença, em particular de um distúrbio hiperproliferativo e/ou angiogênese, mais particularmente para o tratamento ou profilaxia de um câncer, particularmente câncer de pulmão, em particular carcinoma de pulmão de célula não pequena, câncer colorretal, melanoma, câncer pancreático, carcinoma de hepa
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充